SGP — SPYGLASS PHARMA INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 57 SEC-registered investment managers reported holding SGP (SPYGLASS PHARMA INC) in their latest 13F filings, with a combined reported value of $599.79M across 27.64M shares. That is +4.1% by share count (+1.07M shares) versus the previous quarter, while reported value moved -10.2%. Ownership is concentrated: the five largest holders account for 77.0% of reported value and the top ten for 88.1%.
Compared with the prior quarter, 24 opened new positions, 17 added to existing stakes, 6 trimmed, 6 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of SPYGLASS PHARMA INC (SGP) include RA CAPITAL MANAGEMENT, L.P., NEA Management Company, LLC, Sands Capital Alternatives, LLC, ranked by reported 13F value among the 78 institutional holders on this page.
SGP is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 48 | 6.49M | $170.03M | +13.6% |
| Q2 2026 | 57 | 27.64M | $599.79M | +4.1% |
| Q1 2026 | 39 | 26.59M | $669.15M | +0.0% |
| Q4 2025 | 1 | 1 | $28 | +0.0% |
| Q3 2025 | 1 | 1 | $28 | +0.0% |
| Q2 2025 | 1 | 1 | $28 | +0.0% |
| Q1 2025 | 1 | 1 | $28 | +0.0% |
| Q4 2024 | 1 | 1 | $28 | +0.0% |
Over the 8 quarters shown, institutional share counts increased 648682400% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q2 2026 (+4.1%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 2.50M | $65.00M | 9.62% | Hold | |
| 1.00M | $25.52M | 0.00% | Add | |
| 660.82K | $17.18M | 0.00% | Add | |
| 630.41K | $16.39M | 0.00% | Reduce | |
| 506.50K | $13.17M | 0.02% | Add | |
| 233.41K | $8.04M | 0.00% | Hold | |
| 237.17K | $6.17M | 0.00% | Reduce | |
| 176.87K | $4.60M | 0.00% | Add | |
| 76.98K | $1.96M | 0.00% | Add | |
| 65.02K | $1.69M | 0.00% | Reduce | |
| 57.35K | $1.49M | 0.00% | Reduce | |
| 45.94K | $1.19M | 0.00% | Add | |
| 44.30K | $1.15M | 0.01% | Add | |
| 41.42K | $1.08M | 0.57% | New | |
| 38.94K | $1.01M | 0.00% | Add | |
| 30.31K | $788.16K | 0.00% | Add | |
| 29.85K | $776.10K | 0.00% | Add | |
| 22.62K | $588.12K | 0.00% | Reduce | |
| 17.21K | $447.43K | 0.10% | Reduce | |
| 12.22K | $317.85K | 0.00% | Add | |
| 11.96K | $310.99K | 0.00% | Reduce | |
| 11.90K | $309.53K | 0.00% | New | |
| 7.93K | $206.21K | 0.00% | Reduce | |
| 7.74K | $201.14K | 0.00% | New | |
| 3.54K | $92.04K | 0.00% | Add |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 8.02M | $207.83M | 2.20% | New | |
| 7.39M | $191.53M | 10.89% | New | |
| 2.50M | $64.78M | 15.38% | New | |
| 2.11M | $54.67M | 5.31% | New | |
| 704.44K | $18.25M | 0.00% | New | |
| 666.76K | $17.28M | 0.48% | New | |
| 550.00K | $14.25M | 0.19% | New | |
| 577.11K | $13.49M | 0.00% | New | |
| 468.79K | $12.15M | 0.01% | New | |
| 468.79K | $12.15M | 0.02% | New | |
| 434.81K | $11.27M | 0.00% | New | |
| 375.00K | $9.72M | 0.87% | New | |
| 300.00K | $7.77M | 0.00% | New | |
| 250.00K | $6.48M | 0.35% | New | |
| 220.45K | $5.71M | 0.01% | New | |
| 144.74K | $3.75M | 0.00% | New | |
| 126.54K | $3.28M | 0.00% | New | |
| 95.00K | $2.46M | 1.36% | New | |
| 59.78K | $1.55M | 0.00% | New | |
| 59.61K | $1.54M | 0.00% | New | |
| 59.61K | $1.54M | 0.00% | New | |
| 57.00K | $1.48M | 0.00% | New | |
| 47.58K | $1.23M | 0.00% | New | |
| 44.48K | $1.15M | 0.00% | New | |
| 29.35K | $760.41K | 0.00% | New |
Q4 2025 — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1 | $28 | 0.00% | Hold |
Q3 2025 — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1 | $28 | 0.00% | Hold |
Q2 2025 — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1 | $28 | 0.00% | Hold |
New Positions (Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 277.32K sh · $6.18M
- Sixth Street Partners Management Company, L.P. 85.68K sh · $1.91M
- ALPS ADVISORS INC 33.93K sh · $755.33K
- BNY Mellon 23.94K sh · $532.99K
- Virtus Investment Advisers, LLC 17.74K sh · $394.98K
- Nuveen, LLC 14.65K sh · $326.09K
- RHUMBLINE ADVISERS 11.84K sh · $263.64K
- Deutsche Bank AG 10.96K sh · $244.01K
- Wells Fargo & Co 9.85K sh · $219.31K
- MetLife Investment Management, LLC 6.99K sh · $155.51K
- NEW YORK STATE COMMON RETIREMENT FUND 5.40K sh · $120.20K
- Citigroup Inc 5.19K sh · $115.53K
Fully Exited (vs previous quarter)
- First Light Asset Management, LLC sold 375.00K sh · $9.72M
- Monashee Investment Management LLC sold 95.00K sh · $2.46M
- Marshall Wace sold 29.35K sh · $760.41K
- Goldman Sachs Group sold 19.28K sh · $499.62K
- STATE STREET CORP sold 17.25K sh · $446.95K
- Squarepoint Ops LLC sold 7.81K sh · $202.38K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sands Capital Alternatives, LLC | 2.50M | 2.50M | 2.50M | — | — | — | — | — | — | — | — | — | — |
| JPMorgan Chase & Co | 1.00M | 629.74K | 577.11K | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 660.82K | 434.42K | 434.81K | — | — | — | — | — | — | — | — | — | — |
| BlackRock Inc | 630.41K | 711.71K | 144.74K | — | — | — | — | — | — | — | — | — | — |
| Aberdeen Group plc | 506.50K | 493.08K | 220.45K | — | — | — | — | — | — | — | — | — | — |
| Franklin Resources | 233.41K | 233.41K | 300.00K | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 237.17K | 277.32K | 126.54K | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 176.87K | — | 17.25K | — | — | — | — | — | — | — | — | — | — |
| TD ASSET MANAGEMENT INC | 76.98K | 47.58K | 47.58K | — | — | — | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 65.02K | 75.81K | 3.68K | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 57.35K | 68.50K | 59.78K | — | — | — | — | — | — | — | — | — | — |
| Manulife Financial | 45.94K | 12.50K | 11.87K | — | — | — | — | — | — | — | — | — | — |
| ALPS ADVISORS INC | 44.30K | 33.93K | — | — | — | — | — | — | — | — | — | — | — |
| Propel Bio Management, LLC | 41.42K | — | — | — | — | — | — | — | — | — | — | — | — |
| Russell Investments Group, Ltd. | 38.94K | 886 | — | — | — | — | — | — | — | — | — | — | — |
| Morgan Stanley | 30.31K | 8.92K | 4.18K | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 29.85K | 7.95K | 455 | — | — | — | — | — | — | — | — | — | — |
| BNY Mellon | 22.62K | 23.94K | — | — | — | — | — | — | — | — | — | — | — |
| Virtus Investment Advisers, LLC | 17.21K | 17.74K | — | — | — | — | — | — | — | — | — | — | — |
| RHUMBLINE ADVISERS | 12.22K | 11.84K | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold SGP?
As of 2026-Q2, 57 institutional funds reported holding SGP (SPYGLASS PHARMA INC) in SEC 13F filings, with a combined reported value of $599.79M.
How many shares of SGP do institutions own?
13F filers reported 27.64M shares of SGP, worth $599.79M in aggregate at the end of 2026-Q2.
Is institutional ownership of SGP rising or falling?
Share counts moved +4.1% versus the prior quarter — accumulation.
Who are the top institutional holders of SGP?
The largest 13F holders are RA CAPITAL MANAGEMENT, L.P., NEA Management Company, LLC, Sands Capital Alternatives, LLC, Samsara BioCapital, LLC, JPMorgan Chase & Co; the top 25 are ranked at the top of this page.
Who are the major shareholders of SPYGLASS PHARMA INC?
The major shareholders of SPYGLASS PHARMA INC (SGP) by reported 13F value are RA CAPITAL MANAGEMENT, L.P., NEA Management Company, LLC, Sands Capital Alternatives, LLC, Samsara BioCapital, LLC, JPMorgan Chase & Co, among 78 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.